Overexpression of leptin receptors correlated with worse progression-free survival and contrastingly decreased levels of leptin have been reported with ovarian cancer progression (Kato et al., 2015; Uddin et al., 2009). The gene discussed is LEP; the disease is ovarian carcinoma.